Portal:RareDisease/FeaturedPathways
From WikiPathways
(Difference between revisions)
Line 62: | Line 62: | ||
|width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling}} | |width=100px|{{#pwImage:Pathway:WP4844|250px||The influence of laminopathies on Wnt signaling}} | ||
|width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}} | |width=100px|{{#pwImage:Pathway:WP4842|250px||Mammalian disorder of sexual development}} | ||
- | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP4871|250px||Kisspeptin/Kisspeptin Receptor System in the Ovary}} |
|} | |} | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
Line 124: | Line 124: | ||
* [[Pathway:WP4844]] - The influence of laminopathies on Wnt signaling | * [[Pathway:WP4844]] - The influence of laminopathies on Wnt signaling | ||
* [[Pathway:WP4842]] - Mammalian disorder of sexual development | * [[Pathway:WP4842]] - Mammalian disorder of sexual development | ||
- | * [[Pathway: | + | * [[Pathway:WP4871]] - Kisspeptin/Kisspeptin Receptor System in the Ovary |
* [[Pathway:WP4838]] - Regucalcin in proximal tubule epithelial kidney cells | * [[Pathway:WP4838]] - Regucalcin in proximal tubule epithelial kidney cells | ||
* [[Pathway:WP4835]] - Peroxiredoxin 2 induced ovarian failure | * [[Pathway:WP4835]] - Peroxiredoxin 2 induced ovarian failure |
Revision as of 07:51, 23 April 2020
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
List of featured pathways:
- Pathway:WP3584 - MECP2 and Associated Rett Syndrome
- Pathway:WP2447 - Amyotrophic lateral sclerosis (ALS)
- Pathway:WP3569 - Fanconi Anemia Pathway
- Pathway:WP4320 - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
- Pathway:WP4299 - Lamin A-processing pathway
- Pathway:WP4298 - Viral Acute Myocarditis
- Pathway:WP4156 - Disorders of Phenylalanine and Tetrahydrobiopterin
- Pathway:WP4506 - Tyrosine Metabolism
- Pathway:WP4292 - Sulphur Amino Acids
- Pathway:WP4259 - Disorders of Folate Metabolism and Transport
- Pathway:WP4288 - MTHFR deficiency
- Pathway:WP4228 - Vitamine B6-Dependent and Responsive Disorders
- Pathway:WP4507 - Molybdenum (Moco) cofactor biosynthesis
- Pathway:WP4504 - Cysteine and Methionine catabolism
- Pathway:WP4271 - Vitamin B12 Disorders
- Pathway:WP4297 - Thiamine Disorders
- Pathway:WP4236 - Disorders of the Krebs Cycle
- Pathway:WP4153 - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
- Pathway:WP4220 - Neurotransmitter Disorders
- Pathway:WP4224 - Purine Disorders
- Pathway:WP4225 - Pyrimidine Disorder
- Pathway:WP4540 - Pathways Regulating Hippo Signaling
- Pathway:WP4541 - po-Merlin Signaling Dysregulation
- Pathway:WP4518 - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
- Pathway:WP4519 - Cerebral Organic Acidurias
- Pathway:WP4521 - Glycosylation and related congenital defects
- Pathway:WP4522 - Metabolic pathway of LDL, HDL and TG
- Pathway:WP4523 - Classical pathway of steroidogenesis, including diseases
- Pathway:WP4524 - The alternative pathway of fetal androgen synthesis
- Pathway:WP4549 - Fragile X Syndrome
- Pathway:WP4577 - WDR45 autophagy related pathway
- Pathway:WP4312 - Rett syndrome causing genes
- Pathway:WP3995 - Prion disease pathway
- Pathway:WP3853 - ERK Pathway in Huntington's Disease
- Pathway:WP4535 - Envelope proteins and their potential roles in EDMD physiopathology
- Pathway:WP2371 - Parkinsons Disease Pathway
- Pathway:WP2059 - Alzheimers Disease
- Pathway:WP4657 - 22q11.2 Deletion Syndrome
- Pathway:WP4656 - Joubert Syndrome
- Pathway:WP4746 - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
- Pathway:WP4673 - Genes involved in male infertility
- Pathway:WP4844 - The influence of laminopathies on Wnt signaling
- Pathway:WP4842 - Mammalian disorder of sexual development
- Pathway:WP4871 - Kisspeptin/Kisspeptin Receptor System in the Ovary
- Pathway:WP4838 - Regucalcin in proximal tubule epithelial kidney cells
- Pathway:WP4835 - Peroxiredoxin 2 induced ovarian failure
- Pathway:WP4830 - GDNF/RET signalling axis
- Pathway:WP4818 - Conversion of Angiotensinogen to Angiotensin II
- Pathway:WP4792 - Purine metabolism
- Pathway:WP4823 - Genes controlling renal nephrogenesis
- Pathway:WP4814 - Somatic Sex determination
- Pathway:WP4905 - 1q21.1 copy number variation syndrome
- Pathway:WP4906 - 3q29 copy number variation syndrome